Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH -- Ignore unavailable to you. Want to Upgrade?

To: AV8R who wrote (361)	12/14/1998 4:13:00 PM
From: Bear Down	Read Replies (3) \| Respond to of 1084

The problem seems to be that all the good news is about the use of cord blood. I have seen very little mention of ASTM connected with it. For all you longs, I appreciate the medical possibilities of using coed blood. I am all for it. I also understand ASTM connection with them being the first to be able to replicate corb blood cells. I think there is a lot of promise here medicaly. I just don't think ASTM was worthy of a 100% + gain in market cap following a few good results from cord blood. I'm not even sure if cord blood turns out to be the best thing since pennicillian that it will result in ASTM "going to the moon"....